Bitcoin soars past $40,000 for the first time

GlobeNewswire

Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference

AUSTIN, TX and DURHAM, NC, Jan. 07, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will present at the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Presentation Details Conference: H.C. Wainwright BioConnect 2021 Conference Presenter: Andrew Neill, Shattuck’s Vice President of Finance and Corporate Strategy Date: January 11, 2021 Time: 6:00 a.m. EST Webcast Link: Available HereThe presentation will be available on-demand through the H.C. Wainwright conference portal and available on the Events & Presentations section of the Company’s website. A replay of the webcast will be archived for up to 90 days following the presentation date.About Shattuck Labs, Inc. Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck’s proprietary Agonist Redirected Checkpoint, ARC®, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The company’s lead wholly owned program, SL-172154 (SIRPα-Fc-CD40L), which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in collaboration with Takeda Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager, GADLENâ„¢, platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer. Shattuck has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit: www.ShattuckLabs.com.Investor Contact: Conor Richardson Senior Director, Finance & Investor Relations Shattuck Labs, Inc. [email protected] Contact: Stephanie Ascher Managing Director Stern Investor Relations, Inc. [email protected]

Source link

The post Bitcoin soars past $40,000 for the first time appeared first on TechFans.